These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29602011)

  • 1. TransArterial ChemoEmbolization (TACE) with platinum versus anthracyclines for hepatocellular carcinoma: A meta-analysis.
    Zhao M; Xiang P; Jiang H
    Int J Surg; 2018 May; 53():151-158. PubMed ID: 29602011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.
    Cao DD; Xu HL; Liu L; Zheng YF; Gao SF; Xu XM; Ge W
    Oncotarget; 2017 Jul; 8(27):44976-44993. PubMed ID: 28402958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of cTACE versus DEB-TACE in patients with hepatocellular carcinoma: a meta-analysis.
    Zou JH; Zhang L; Ren ZG; Ye SL
    J Dig Dis; 2016 Aug; 17(8):510-517. PubMed ID: 27384075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.
    Leng JJ; Xu YZ; Dong JH
    ANZ J Surg; 2016 Oct; 86(10):816-820. PubMed ID: 25088384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Wang D; Su C; Li H; Guo X
    Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Huo YR; Eslick GD
    JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
    Song P; Hai Y; Ma W; Zhao L; Wang X; Xie Q; Li Y; Wu Z; Li Y; Li H
    Medicine (Baltimore); 2018 May; 97(18):e0613. PubMed ID: 29718867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
    Liao M; Zhu Z; Wang H; Huang J
    Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.
    Lobo L; Yakoub D; Picado O; Ripat C; Pendola F; Sharma R; ElTawil R; Kwon D; Venkat S; Portelance L; Yechieli R
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1580-1588. PubMed ID: 27586657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma.
    Chua TC; Liauw W; Saxena A; Chu F; Glenn D; Chai A; Morris DL
    Liver Int; 2010 Feb; 30(2):166-74. PubMed ID: 19912531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.
    Oliveri RS; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2011 Mar; (3):CD004787. PubMed ID: 21412886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter Arterial Chemoembolization Plus
    Zhu ZX; Liao MH; Wang XX; Huang JW
    Korean J Radiol; 2016; 17(6):882-892. PubMed ID: 27833404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide Combined with Transcatheter Arterial Chemoembolization (TACE) for Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and GRADE Approach.
    Yang W; Wang D; Huang L; Chen Y; Wen S; Hong Q; Kang D
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2043-2055. PubMed ID: 30139041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
    Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
    World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
    Yi PS; Huang M; Zhang M; Xu L; Xu MQ
    Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
    Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
    Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of transarterial chemoembolization plus sorafenib for early or intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials.
    Zeng J; Lv L; Mei ZC
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):688-697. PubMed ID: 27339594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.